Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.
Journal: Blood cancer journal
Published: July 15, 2025
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.
Journal: Blood neoplasia
Published: March 10, 2025
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: February 15, 2025
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 03, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101).
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2024
Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: November 03, 2023
CAR T cell therapy-related lumbosacral polyradiculopathy with myelitis and stiff person syndrome with response to intravenous immunoglobulin and corticosteroids in a patient with acute lymphoblastic leukemia.
Journal: Hematology, transfusion and cell therapy
Published: August 25, 2023
A social enterprise model for TB detection and treatment through the private sector in Pakistan.
Journal: IJTLD open
Published: August 10, 2023
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Journal: British journal of haematology
Published: March 15, 2023
CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 07, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Journal: American journal of hematology
Published: November 07, 2022
Last Updated: 09/26/2026